<?xml version="1.0" encoding="UTF-8"?>
<p id="Par8">The majority of the publications included patients who underwent DBS surgery with implantation in STN. However, a few reported patients with severe troublesome dyskinesia had GPi implantation.
 <sup>
  <xref ref-type="bibr" rid="CR13">13</xref>–
  <xref ref-type="bibr" rid="CR20">20</xref>
 </sup> Only one mutation-positive patient (
 <italic>GBA</italic>) was treated with VIM stimulation.
 <sup>
  <xref ref-type="bibr" rid="CR20">20</xref>
 </sup> A number of different outcome measures are used to assess DBS treatment response and safety; the most commonly used being the Unified Parkinson’s Disease Rating Scale (UPDRS) and levodopa equivalent daily dose (LEDD) reduction.
</p>
